Cargando…

Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA

Transcription factors (TFs) have been introduced to drive the highly efficient differentiation of human-induced pluripotent stem cells (hiPSCs) into lineage-specific oligodendrocytes (OLs). However, effective strategies currently rely mainly on genome-integrating viruses. Here we show that a synthet...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian, Yang, Zhihua, Wang, Rui, He, Fumei, Yan, Rong, Zhang, Yidi, Yu, Liying, Deng, Wenbin, Nie, Yichu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568531/
https://www.ncbi.nlm.nih.gov/pubmed/36241911
http://dx.doi.org/10.1038/s42003-022-04043-y
_version_ 1784809658522796032
author Xu, Jian
Yang, Zhihua
Wang, Rui
He, Fumei
Yan, Rong
Zhang, Yidi
Yu, Liying
Deng, Wenbin
Nie, Yichu
author_facet Xu, Jian
Yang, Zhihua
Wang, Rui
He, Fumei
Yan, Rong
Zhang, Yidi
Yu, Liying
Deng, Wenbin
Nie, Yichu
author_sort Xu, Jian
collection PubMed
description Transcription factors (TFs) have been introduced to drive the highly efficient differentiation of human-induced pluripotent stem cells (hiPSCs) into lineage-specific oligodendrocytes (OLs). However, effective strategies currently rely mainly on genome-integrating viruses. Here we show that a synthetic modified messenger RNA (smRNA)-based reprogramming method that leads to the generation of transgene-free OLs has been developed. An smRNA encoding a modified form of OLIG2, in which the serine 147 phosphorylation site is replaced with alanine, OLIG2(S147A), is designed to reprogram hiPSCs into OLs. We demonstrate that repeated administration of the smRNA encoding OLIG2 (S147A) lead to higher and more stable protein expression. Using the single-mutant OLIG2 smRNA morphogen, we establish a 6-day smRNA transfection protocol, and glial induction lead to rapid NG2(+) OL progenitor cell (OPC) generation (>70% purity) from hiPSC. The smRNA-induced NG2(+) OPCs can mature into functional OLs in vitro and promote remyelination in vivo. Taken together, we present a safe and efficient smRNA-driven strategy for hiPSC differentiation into OLs, which may be utilized for therapeutic OPC/OL transplantation in patients with neurodegenerative disease.
format Online
Article
Text
id pubmed-9568531
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95685312022-10-16 Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA Xu, Jian Yang, Zhihua Wang, Rui He, Fumei Yan, Rong Zhang, Yidi Yu, Liying Deng, Wenbin Nie, Yichu Commun Biol Article Transcription factors (TFs) have been introduced to drive the highly efficient differentiation of human-induced pluripotent stem cells (hiPSCs) into lineage-specific oligodendrocytes (OLs). However, effective strategies currently rely mainly on genome-integrating viruses. Here we show that a synthetic modified messenger RNA (smRNA)-based reprogramming method that leads to the generation of transgene-free OLs has been developed. An smRNA encoding a modified form of OLIG2, in which the serine 147 phosphorylation site is replaced with alanine, OLIG2(S147A), is designed to reprogram hiPSCs into OLs. We demonstrate that repeated administration of the smRNA encoding OLIG2 (S147A) lead to higher and more stable protein expression. Using the single-mutant OLIG2 smRNA morphogen, we establish a 6-day smRNA transfection protocol, and glial induction lead to rapid NG2(+) OL progenitor cell (OPC) generation (>70% purity) from hiPSC. The smRNA-induced NG2(+) OPCs can mature into functional OLs in vitro and promote remyelination in vivo. Taken together, we present a safe and efficient smRNA-driven strategy for hiPSC differentiation into OLs, which may be utilized for therapeutic OPC/OL transplantation in patients with neurodegenerative disease. Nature Publishing Group UK 2022-10-14 /pmc/articles/PMC9568531/ /pubmed/36241911 http://dx.doi.org/10.1038/s42003-022-04043-y Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Xu, Jian
Yang, Zhihua
Wang, Rui
He, Fumei
Yan, Rong
Zhang, Yidi
Yu, Liying
Deng, Wenbin
Nie, Yichu
Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA
title Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA
title_full Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA
title_fullStr Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA
title_full_unstemmed Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA
title_short Rapid differentiation of hiPSCs into functional oligodendrocytes using an OLIG2 synthetic modified messenger RNA
title_sort rapid differentiation of hipscs into functional oligodendrocytes using an olig2 synthetic modified messenger rna
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568531/
https://www.ncbi.nlm.nih.gov/pubmed/36241911
http://dx.doi.org/10.1038/s42003-022-04043-y
work_keys_str_mv AT xujian rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT yangzhihua rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT wangrui rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT hefumei rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT yanrong rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT zhangyidi rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT yuliying rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT dengwenbin rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna
AT nieyichu rapiddifferentiationofhipscsintofunctionaloligodendrocytesusinganolig2syntheticmodifiedmessengerrna